You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selective Estrogen Receptor Modulator

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

Active, not recruiting
Has Results
  • Androgen Receptor Positive
  • +5 more
  • Corona, California
  • +6 more
Jun 8, 2022

Metastatic Breast Cancer Trial in United States (Sabizabulin, Exemestane monotherapy, exemestane plus everolimus, or selective

Not yet recruiting
  • Metastatic Breast Cancer
  • Sabizabulin
  • Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator
  • Anchorage, Alaska
  • +25 more
Dec 22, 2022

Leiomyoma Trial run by the NICHD (ulipristal acetate 20 mg, ulipristal acetate 10 mg, )

Completed
Has Results
  • Leiomyoma
  • ulipristal acetate 20 mg
  • +2 more
  • Bethesda, Maryland
  • +1 more
Feb 14, 2022

Schizophrenia, Schizophreniform Disorders, Schizo Affective Disorder Trial in Melbourne (Bazedoxifene Acetate, Placebo)

Recruiting
  • Schizophrenia
  • +2 more
  • Bazedoxifene Acetate
  • Placebo
  • Melbourne, Victoria, Australia
    Monash Alfred Psychiatry Research Centre
Jan 6, 2020

Prostate Cancer Trial in Gainesville, Baltimore, Boston (LY2452473, Placebo)

Completed
Has Results
  • Prostate Cancer
  • Gainesville, Florida
  • +3 more
Sep 27, 2021

Clomiphene Citrate asInhibitor of Ovulation inOocyte

Not yet recruiting
  • Infertility, Female
  • Infertility
  • Baton Rouge, Louisiana
    Womans Hospital
May 17, 2023

HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

Active, not recruiting
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +13 more
Jan 13, 2022

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Breast Cancer. Real Clinical Practice in Russia

Recruiting
  • Breast Cancer
  • Neoadjuvant Endocrine Therapy
  • Tamoxifen 20mg
  • +4 more
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 5, 2023

Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

Recruiting
  • Metastatic Breast Cancer
  • Anchorage, Alaska
  • +58 more
Jan 6, 2023

Endometriosis Trial in New Haven (simvastatin 10mg, Bazedoxifene 20/Estrogens,Con 0.45Mg Tb, Placebo)

Recruiting
  • Endometriosis
  • simvastatin 10mg
  • +2 more
  • New Haven, Connecticut
    The John B. Pierce Laboratory
Dec 8, 2022

Breast Cancer Recurrent Trial in Worldwide (Palbociclib 125mg, Standard endocrine therapy)

Recruiting
  • Breast Cancer Recurrent
  • Palbociclib 125mg
  • Standard endocrine therapy
  • Graz, Austria
  • +52 more
Nov 15, 2022

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Utrecht (Raloxifene, Placebo)

Completed
  • Schizophrenia
  • +3 more
  • Utrecht, Netherlands
    UMC Utrecht
Oct 4, 2021

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Jul 11, 2023

Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer, Early-Onset
  • (no location specified)
Jan 18, 2023

Clomiphene Citrate, Resistant Ovary Syndrome, Polycystic Ovary Syndrome Trial in Bani Suwayf, Giza (Alpha lipoic acid (ALA),

Recruiting
  • Clomiphene Citrate
  • +2 more
  • Alpha lipoic acid (ALA)
  • +2 more
  • BanÄ« Suwayf, Egypt
  • +2 more
Jan 1, 2023

Breast Cancer Metastatic Trial in Worldwide (Amcenestrant, Fulvestrant, Anastrozole)

Active, not recruiting
  • Breast Cancer Metastatic
  • Birmingham, Alabama
  • +121 more
Apr 28, 2022

Increased Risk for Development of Breast Cancer Trial in Kansas City (bazedoxifene plus conjugated estrogens)

Recruiting
  • Increased Risk for Development of Breast Cancer
  • bazedoxifene plus conjugated estrogens
  • Kansas City, Kansas
    University of Kansas Medical Center
Jan 9, 2022

Benign Prostatic Hyperplasia Trial in United States (Group-1 (15mg, OPK-88004), Group-2 (25 mg,OPK-88004), Placebo)

Terminated
Has Results
  • Benign Prostatic Hyperplasia
  • Group-1 (15mg, OPK-88004)
  • +2 more
  • Anniston, Alabama
  • +14 more
Aug 23, 2021

Menopause, Prediabetes, Obesity Trial in New Orleans (Placebo, conjugated estrogens/bazedoxifene (CE/BZA))

Not yet recruiting
  • Menopause
  • +2 more
  • Placebo
  • conjugated estrogens/bazedoxifene (CE/BZA)
  • New Orleans, Louisiana
    Southeast Louisiana Veterans Health Care System, New Orleans, LA
Jan 12, 2023

Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension Trial in Nashville (Tamoxifen, Placebo

Recruiting
  • Hypertension
  • +8 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 22, 2022

Breast Cancer Trial in Port Saint Lucie (RGT-419B, RGT-419B in combination with hormonal therapy)

Recruiting
  • Breast Cancer
  • RGT-419B
  • RGT-419B in combination with hormonal therapy
  • Port Saint Lucie, Florida
    Hem-Onc Associates of the Treasure Coast
Apr 18, 2022

Focus of Study is Healthy Women at Risk for Breast Cancer Trial in Kansas City (DUAVEE 0.45Mg-20Mg Tablet)

Terminated
  • Focus of Study is Healthy Women at Risk for Breast Cancer
  • DUAVEE 0.45Mg-20Mg Tablet
  • Kansas City, Kansas
    University of Kansas Medical Center
Oct 22, 2021

Factors Influencing Decision-Making About Use of Chemoprevention

Completed
  • Breast Cancer
  • Counseling session
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 4, 2021